Related Experiment Video
Updated: May 5, 2026

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
Published on: August 18, 2015
The effects of thrombolytic therapy on the high-resolution electrocardiogram after myocardial infarction
M Mäkijärvi1, J Heikkilä, J Montonen
1Helsinki University Central Hospital, First Department of Medicine, Finland.
Insights
Thrombolytic treatment for acute myocardial infarction significantly shortened filtered QRS duration in reperfused patients. Early thrombolysis (within 2 hours) showed improved ECG markers, suggesting better outcomes.
Area of Science:
- Cardiology
- Medical Imaging
- Biomedical Engineering
Background:
- Acute myocardial infarction (AMI) remains a leading cause of mortality.
- Thrombolytic therapy is a critical treatment for AMI, aiming to restore blood flow.
- Assessing treatment efficacy non-invasively is crucial for patient management.
Purpose of the Study:
- To evaluate the effects of thrombolytic treatment on electrocardiographic (ECG) parameters in patients post-myocardial infarction.
- To correlate ECG findings with treatment success and timing.
- To investigate specific ECG markers indicative of successful reperfusion.
Main Methods:
- High-resolution ECG, 24-hour Holter monitoring, exercise testing, and radionuclide ventriculography were used.
- Analysis included filtered QRS duration and root mean square (RMS) voltage of the QRS complex.
- Patients were categorized into treated (thrombolysis) and control groups.
Main Results:
- Filtered QRS duration was significantly shorter in reperfused patients (83 ± 10 ms) compared to controls (89 ± 12 ms; P=0.017).
- In inferior infarcts, reperfused patients had shorter filtered QRS duration (83 ± 11 ms vs. 89 ± 10 ms; P=0.044).
- Higher RMS voltage in anteroseptal infarcts and earlier treatment groups indicated successful reperfusion.
Conclusions:
- Thrombolytic therapy significantly impacts ECG parameters, particularly filtered QRS duration, in reperfused myocardial infarction.
- Specific ECG metrics, like RMS voltage, can serve as indicators of successful reperfusion and treatment timing.
- These findings support the use of advanced ECG analysis for assessing thrombolytic therapy effectiveness.
Abstract:
The effects of thrombolytic treatment was studied in 109 consecutive patients 9-11 days after their first acute myocardial infarction by high-resolution electrocardiography (ECG), 24 h Holter monitoring, exercise test and radionuclide ventriculography. Thirty-seven patients were treated with intravenous thrombolytic agents. Thrombolytic treatment was assessed by clinical criteria to be successful in 22 patients and probably successful in 12 patients. Thrombolysis failed in three patients and 72 patients did not receive thrombolytic treatment (control group). Measurements made on the high-resolution and filtered (60 Hz high-pass) vectormagnitude complex included the total duration, the duration of the potential less than 40 microV, the root mean square (RMS) voltage in 10 ms intervals over the first 50 ms and RMS voltage of the last 40, 50 and 60 ms. The filtered QRS duration was significantly shorter in reperfused patients compared with the control group (83 +/- 10 vs 89 +/- 12 ms; P = 0.017). In inferior infarcts (n = 57) the filtered QRS duration was 83 +/- 11 ms in reperfused and 89 +/- 10 ms in non-reperfused patients (P = 0.044), but in anterior infarcts (n = 52) there was no difference. The RMS voltage of the initial 50 ms of the QRS was higher in the reperfused than in non-reperfused anteroseptal infarcts (38 +/- 14 v 23 +/- 10 microV; P = 0.022). Patients successfully treated with thrombolytic agents within the first 2 h had higher RMS voltage of the terminal 40 ms of the QRS than patients treated within 2-4 h (38 +/- 17 vs 27 +/- 17 microV; P = 0.03).(ABSTRACT TRUNCATED AT 250 WORDS)
More Related Videos
Related Concept Videos
Electrocardiogram
Three major waveforms are present in a typical ECG recording: the P wave, the QRS complex, and...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome IV: Interprofessional Care

